Confronting Advanced HIV Disease: Why It Still Matters

When we talk about HIV in 2025, the story we often hear is about progress: more people than ever are on treatment, new prevention methods are available, and the science of HIV cure is advancing. Yet, behind this progress lies a quieter crisis, Advanced HIV Disease (AHD).

What Is Advanced HIV Disease?

The World Health Organisation (WHO) defines Advanced HIV Disease as when a person has a CD4 count below 200 cells/mm³ or is in WHO clinical stage 3 or 4. For children younger than five years, any HIV infection is considered advanced because of their high vulnerability. People with AHD are extremely vulnerable to severe opportunistic infections such as cryptococcal meningitis, tuberculosis, histoplasmosis, and Pneumocystis pneumonia, alongside weight loss, persistent fevers, and other life-threatening complications.

Why Does AHD Still Happen?

One might ask: If treatment is widely available, why are people still reaching this stage? The reasons are complex:

  • Late diagnosis: WHO data show that at least one-third of people entering HIV care present with advanced HIV disease, based on an analysis of over 1.8 million individuals across 117 cohorts in 52 countries. In sub-Saharan Africa, between 20% and 40% of people living with HIV still present with AHD at the time of diagnosis or when re-engaging in care.
  • Treatment interruption: Many people disengage from care due to stigma, side-effects, migration, or health system failures, and return to care much later.
  • Health system gaps: Not all facilities are equipped to provide the full “AHD package of care,” including rapid diagnostics, access to life-saving medicines, and appropriate hospital or palliative care.
  • Social and structural barriers: Poverty, gender inequality, discrimination, and criminalisation of key populations often block people from accessing services early.

The Human Cost

AHD is not just a clinical condition; it is a story of human suffering. People often arrive in hospitals very ill, sometimes dying within days of admission. Families face not only grief but also stigma and financial strain. Globally, over 4 million adults are estimated to be living with AHD, and in 2021 alone, there were around 650,000 HIV-related deaths, most linked to advanced disease or complications that could have been prevented with timely care.

What Needs to Be Done

The good news is that AHD is preventable and treatable, if health systems respond effectively. Solutions include:

  • Routine screening and early intervention: Using CD4 testing and point-of-care diagnostics to identify people at risk.
  • The AHD package of care: WHO recommends a combination of prophylaxis, rapid diagnosis, and treatment for major opportunistic infections, plus ART re-initiation.
  • Stronger hospital-to-community linkages: Many patients die after being discharged because they are not properly followed up. Continuity of care is essential.
  • Integration of palliative care: Beyond survival, people with AHD need relief from pain and distress.
  • Community engagement: PLHIV networks and support groups must be central, addressing stigma, offering peer navigation, and supporting adherence.

Why This Matters Now

As we celebrate advances in HIV prevention, treatment, and cure research, we cannot forget those still being left behind. AHD reminds us that equity is the unfinished business of the HIV response. Global health leaders, governments, and communities must prioritise AHD, not as a remnant of the past, but as an urgent challenge today.

The upcoming Lancet Commission on Advanced HIV Disease, which I am honoured to support, offers an opportunity to shine a light on this neglected crisis. By combining evidence, policy analysis, and community voices, the Commission will help chart a path to reduce preventable suffering and death.

A Call to Action

Ending AIDS is not only about reaching 95-95-95 targets, but also about ensuring no one dies from preventable and treatable conditions. We must invest in stronger health systems, community-centred care, and policies that keep people from falling through the cracks.

Because until we end the suffering caused by Advanced HIV Disease, the story of HIV is not complete.

Comments

  1. I was put on a traditional herbal medicines by Dr Jekawo who resides in west africa, and I am amazed at my healing thus far. I will continue to post what worked for me and what didn't in more blogs to come (as this one is getting quite long... and I'm not writing a book here - not yet anyway). This discovery has not only helped the way I practice, but it has also given me further insight into the world of Herbal  medicine. I came to know more about Dr Jekawo on Tv Station when I was taking my regular organic coffee at javamania coffee spot I watched the whole scene on how he uses Natural herbs to cure disease like Herpes, Hiv/Aids, Cancers,HPV,Men & Women Infertility,Melanoma, Mesothelioma, Multiple myeloma, Neuroendocrine tumors,lymphoma,Alzheimer's disease, chronic diarrhea, COPD, Parkinson's disease, Als And Diabetes, I was moved by his words then I took a confident step to contact him regarding my health condition Herpes & Prostate Cancer, He prepared his herbal medicine then sent it to me through Courier which I took as it's was instructed and I found myself healing symptoms are all gone I have being watching my health for years now and I finally confirmed that is a permanent cure like he told me at our first conversations so now I'm healthy and happy I purchase his herbal tea which I usually take in the morning before starting my day because it feels good to find addiction on natural herbs than medical drugs so is what I'm doing and loving it more and More to come later on blogs sooner I will be writing my book.I will advise you to contact Doctor Jekawo A traditional herbal doctor, for any kind of permanent cure and herbal remedy.Doctor Jekawo Email Contact: drjekawo@gmail.com Also On Web: www.drjekawo.com.

    ReplyDelete

Post a Comment

Popular posts from this blog

Aging with HIV in Botswana: Time to Update Our Treatment Guidelines

HIV Prevention Research in a Time of Scarcity: Why Health Economics Must Lead the Way

Highlights from the HIV Cure Pre-Conference at AIDS 2024